MOG and myeloid sarcoma: Serum antibodies against conformational myelin oligodendrocyte glycoprotein (MOG) have recently been identified as a likely cause of acquired inflammatory demyelination in the central nervous system (CNS), distinct from multiple sclerosis (MS),1, 2, 3 and often referred to as MOG antibody disease (MOGAD).